1-4 of 4
Andrew Gentles
Close
Sort by
Journal Articles

Accelerating Immune Reconstitution in HSCT Patients through iPSC-Derived Thymic Epithelial Cells

Abdulvasey Mohammed, Hanh Dan Nguyen, Kelsea Hubka, Wenqing Wang, Priscila Slepicka, Phd, Ben Solomon, Martin Arreola, Zihao Zheng, Andrew Gentles, Katja G. Weinacht
Journal: Blood
Blood (2023) 142 (Supplement 1): 460.
https://doi.org/10.1182/blood-2023-186901
Published: 2023
Journal Articles

Clonal Architecture and Variant Allele Frequency Predict Clinical Outcomes and Drug Response in Acute Myeloid Leukemia

Brooks Benard, BS, Logan Leak, BS, Armon Azizi, BS, Daniel Thomas, MD PhD, Andrew Gentles, PhD, Ravi Majeti, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2.
https://doi.org/10.1182/blood-2020-136477
Published: 2020
Journal Articles

An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen, MSc, Bogdan A. Luca, PhD, Mohammad Shahrokh Esfahani, Barzin Y. Nabet, PhD, Brian Sworder, MD PhD, Farshad Farshidfar, MD PhD, Kiarash Shamardani, BA, David M. Kurtz, MD PhD, Chih Long Liu, PhD, Ranjana H Advani, MD, Yasodha Natkunam, MD PhD, June Helen Myklebust, PhD, Maximilian Diehn, MD PhD, Andrew Gentles, PhD, Aaron M Newman, PhD, Ash A. Alizadeh, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 655.
https://doi.org/10.1182/blood-2019-129461
Published: 2019
Journal Articles

MYC Oncogene Abrogates Natural Killer (NK) Cell-Mediated Immune Surveillance of B- and T- Lymphoid Malignancies By Suppressing STAT1/2-Type I IFN Signaling

Srividya Swaminathan, PhD, Line Dam Heftdal, MD, Daniel Liefwalker, PhD, Renumathy Dhanasekaran, MD, Anja Deutzmann, PhD, Crista Horton, BS, Adriane Mosley, BS, Mariola Liebersbach, BS, Andrew Gentles, PhD, Holden T. Maecker, PhD, Dean Felsher, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 730.
https://doi.org/10.1182/blood-2019-122607
Published: 2019